%0 Journal Article
%T Pharmacodynamics, safety, and immunogenicity of Pelmeg£¿, a pegfilgrastim biosimilar in healthy subjects
%A Dirk Lehnick
%A Hendrik Wessels
%A Josef H£¿fler
%A Karsten Roth
%A Paul Chamberlain
%A Ruediger Jankowsky
%J Archive of "Pharmacology Research & Perspectives".
%D 2019
%R 10.1002/prp2.507
%K biosimilars
%K filgrastim
%K highly similar
%K myelosuppressive chemotherapy
%K neutropenia
%K oncology
%K pegfilgrastim
%K supportive care
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691755/